London-based biotech startup BoobyBiome has raised €2.8M to transform infant gut health through the breast milk microbiome. Backed by top investors, the female-founded company is developing a patented storage device that preserves the natural microbiome in expressed milk and a live microbiome drop designed to support formula-fed, c-section, or preterm babies. With the world’s largest breast milk microbiome database behind them, the team is tackling rising childhood diseases linked to underdeveloped microbiomes. Could this be the breakthrough that redefines infant nutrition globally?
Keep Reading
Add A Comment